Liver carcinoma | Measurable Lesion Quantity
Item
identify patients with hcc in accordance with the clinical diagnostic criteria of hcc passed at the chines eighth national live cancer academic conference. patients with hcc shall be diagnosed with pathology. there is at least one measurable lesion.
boolean
C2239176 (UMLS CUI [1])
C1513041 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Hepatoma Involved Location Liver segment | Tumor Location Caudate lobe of liver | Tumor Diameter Size | Tumor TNM clinical staging | Lesion Determination | Radical excision Possible | Absence Neoplasm Metastasis Extrahepatic | Absence Tumor Thrombus Portal vein | Absence Tumor Thrombus Hepatic vein | Absence Tumor Thrombus Vena cava | Absence Tumor Thrombus Bile duct
Item
hepatoma involved in this research at complex site is located at the eighth segment of liver, the substantial depth of liver below hepatic integument adjacent to the trunk of inferior vena cava, hepatic vein and portal vein. the tumor is located at hepatic caudate lobe. the maximal diameter < or=3m, ajcc/uicc—tnm stage is stage ii and above. lesions are determined by three senior hepatobiliary experts independently, therefore radical resection is possible. there is no possibility of extra-hepatic metastasis and tumor thrombus of portal vein, hepatic vein, vena cava and bile duct.
boolean
C0023903 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,3])
C0457138 (UMLS CUI [1,4])
C0027651 (UMLS CUI [2,1])
C1515974 (UMLS CUI [2,2])
C0227489 (UMLS CUI [2,3])
C0027651 (UMLS CUI [3,1])
C1301886 (UMLS CUI [3,2])
C0456389 (UMLS CUI [3,3])
C0027651 (UMLS CUI [4,1])
C3258246 (UMLS CUI [4,2])
C0221198 (UMLS CUI [5,1])
C1148554 (UMLS CUI [5,2])
C0184918 (UMLS CUI [6,1])
C0332149 (UMLS CUI [6,2])
C0332197 (UMLS CUI [7,1])
C0027627 (UMLS CUI [7,2])
C1517058 (UMLS CUI [7,3])
C0332197 (UMLS CUI [8,1])
C0027651 (UMLS CUI [8,2])
C0087086 (UMLS CUI [8,3])
C1305775 (UMLS CUI [8,4])
C0332197 (UMLS CUI [9,1])
C0027651 (UMLS CUI [9,2])
C0087086 (UMLS CUI [9,3])
C0019155 (UMLS CUI [9,4])
C0332197 (UMLS CUI [10,1])
C0027651 (UMLS CUI [10,2])
C0087086 (UMLS CUI [10,3])
C1280190 (UMLS CUI [10,4])
C0332197 (UMLS CUI [11,1])
C0027651 (UMLS CUI [11,2])
C0087086 (UMLS CUI [11,3])
C0005400 (UMLS CUI [11,4])
Liver function | Child-Pugh Classification | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Hepatectomy Appropriateness | Minimally Invasive Surgical Procedures Appropriateness
Item
criteria of liver function: child a level, serum bilirubin ≤ 1.5 times the upper limit of normal value, alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value. it's appropriate to perform liver resection and minimally invasive treatment.
boolean
C0232741 (UMLS CUI [1])
C4050412 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0201899 (UMLS CUI [5])
C0019144 (UMLS CUI [6,1])
C0814634 (UMLS CUI [6,2])
C0282624 (UMLS CUI [7,1])
C0814634 (UMLS CUI [7,2])
Absence Dysfunction Organ Major | Hematologic function | Renal function | Cardiac function | Pulmonary function
Item
no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal.
boolean
C0332197 (UMLS CUI [1,1])
C3887504 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0221130 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232164 (UMLS CUI [4])
C0231921 (UMLS CUI [5])
Age | Volunteer | Informed Consent
Item
patients who can understand this trial, male or female, aged 18-70 voluntarily participate in clinical trials and have signed information consent.
boolean
C0001779 (UMLS CUI [1])
C1997894 (UMLS CUI [2])
C0021430 (UMLS CUI [3])
Cardiac dysfunction Affecting Therapy Liver cancer | Pulmonary Dysfunction Affecting Therapy Liver cancer | Brain dysfunction Affecting Therapy Liver cancer | Renal dysfunction Affecting Therapy Liver cancer
Item
patients with apparent cardiac, pulmonary, cerebric and renal dysfunction,which may affect the treatment of liver cancer.
boolean
C3277906 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0345904 (UMLS CUI [1,4])
C1709770 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C0345904 (UMLS CUI [2,4])
C0262405 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
C0345904 (UMLS CUI [3,4])
C3279454 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0087111 (UMLS CUI [4,3])
C0345904 (UMLS CUI [4,4])
Disease Affecting Clinical Trial Therapy
Item
patients with other diseases which may affect the treatment mentioned here.
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
Cancer Other
Item
patients with medical history of other malignant tumors.
boolean
C1707251 (UMLS CUI [1])
Study Subject Participation Status
Item
subjects participating in other clinical trials.
boolean
C2348568 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
women in pregnancy and breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
TNM clinical staging
Item
patients with tumor ajcc/uicc—tnm stage at iiia period or below.
boolean
C3258246 (UMLS CUI [1])